Document de presse | 2020.05.26
Institut Pasteur announces recent advances in the development of one of its candidate vaccines, MV-SARS-CoV-2, using the measles vector, as part of a renewed partnership with CEPI and the companies Thémis and MSD.With over 100 vaccine projects in development worldwide, the development of a vaccine against SARS CoV-2 infection remains a challenge, with many scientific uncertainties ahead. The...
News | 2020.07.27
How do we recognize pitch? An observational study carried out by the Institut Pasteur with the support of the French Society of Authors, Composers and Publishers of Music (SACEM), involving interviews with nearly 70 musicians (music students and professionals), addressed this question and found some initial answers. Musicians recognize pitch by drawing on three mental sensory modalities (auditory...
Document de presse | 2020.09.21
Cocaine addiction is a chronic disorder with a high rate of relapse for which no effective treatment is currently available. Scientists from the Institut Pasteur, the CNRS, Inserm and the Paris Public Hospital Network (AP-HP) recently demonstrated that two gene mutations involved in the conformation of nicotinic receptors in the brain appear to play a role in various aspects of cocaine addiction...
Document de presse | 2023.12.14
International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.The multidisciplinary European consortium MARVAX will receive 7.4 million euros over the next four years for the research and development of vaccines against Marburg viruses. Researchers from France, Spain and Germany will develop novel vaccine candidates, which...
News | 2021.11.24
Homologous recombination is one of the major pathways for repairing broken DNA. A study by scientists from the Institut Pasteur and ENS Lyon shows how a protein known as cohesin reorganizes the genome into loops to enable this process.
Document de presse | 2015.05.25
The European Investment Fund (EIF), Fonds National d’Amorçage (FNA) managed by Bpifrance as part of the French government’s Investments for the future (“Investissements d’Avenir”) program, Institut Pasteur, and BNP Paribas are participating in the first closing (€33M). Press release Paris, May 26, 2015 Kurma Diagnostics: the first Venture Capital...
Document de presse | 2014.06.18
When the body receives an injury to the skin, a signal is sent to the brain, which generates a sensation of pain. Teams led by Priscille Brodin in Lille[1] and Laurent Marsollier in Angers[2] have studied lesions in patients with Buruli ulcer, a tropical disease. In an article published in the journal Cell, they show that, despite the extent and severity of these wounds, they are less painful...
News | 2016.04.28
Bacterial genomes generally contain a single chromosome and one or more extrachromosal elements such as plasmids. The initiation of bacterial chromosome replication must be carefully checked to ensure that chromosome duplication occurs only once per cell cycle. The bacterial pathogen responsible for cholera epidemics, Vibrio cholerae, is distinctive in that it has two chromosomes. The teams led...
News | 2015.09.28
The Dennis and Mireille Gillings Global Public Health Fellowships are a collaboration between the University of Cambridge and the Institut Pasteur. Designed to advance the next generation of public health leaders, the three year post-doctoral fellowships aim to instill financial acumen and business entrepreneurship against a backdrop of research excellence, all at a formative stage in the careers...
News | 2017.06.19
In Senegal the prevalence of malaria declined from over 30% to less than 5% between the early 2000s and 2015 thanks to the implementation of preventive measures recommended by WHO such as Artemisinin-based combination therapy, rapid diagnosis and impregnated mosquito nets. What is the impact of these preventive measures on antimalarial immunity of populations?To answer this question, several...